Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Prime Medicine Inc (NQ: PRME ) 3.460 -0.100 (-2.81%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Prime Medicine Inc < Previous 1 2 3 Next > 2 Growth Stocks That Could Make You Richer August 28, 2024 Discover two cutting-edge growth stocks that could revolutionize medicine and space exploration. Via The Motley Fool Prime Medicine to Participate in Upcoming Investor Conferences August 28, 2024 From Prime Medicine, Inc. Via GlobeNewswire PRME Stock Earnings: Prime Medicine Misses EPS for Q2 2024 August 08, 2024 PRME stock results show that Prime Medicine missed analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Prime Medicine Reports Second Quarter 2024 Financial Results and Provides Business Updates August 08, 2024 From Prime Medicine, Inc. Via GlobeNewswire Prime Medicine to Present at Upcoming Investor Conferences May 30, 2024 From Prime Medicine, Inc. Via GlobeNewswire Recap: Prime Medicine Q4 Earnings March 01, 2024 Via Benzinga If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names May 29, 2024 Between FDA approvals and product pipelines, it takes diligence to keep up with which biotech stocks to buy. Via InvestorPlace Exposures Product Safety Here Are the 2 Growth Stocks Google's Parent Company Just Added to Its $7 Billion Portfolio May 25, 2024 Alphabet may have strong insight into both company's industries. Via The Motley Fool Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for May 2024 May 17, 2024 Discover three biotech stocks handpicked by Cathie Wood, offering groundbreaking therapies and substantial growth potential. Via InvestorPlace Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024 May 17, 2024 With new innovation, millions of retiring baby boomers, and an increase in mergers, biotech stocks to buy have a good deal of upside ahead. Via InvestorPlace Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ May 13, 2024 From Prime Medicine, Inc. Via GlobeNewswire PRME Stock Earnings: Prime Medicine Beats EPS for Q1 2024 May 10, 2024 PRME stock results show that Prime Medicine beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates May 10, 2024 From Prime Medicine, Inc. Via GlobeNewswire Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD) May 08, 2024 From Prime Medicine, Inc. Via GlobeNewswire Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket May 02, 2024 Via Benzinga Prime Medicine to Participate in the 27th Annual Milken Institute Global Conference May 01, 2024 From Prime Medicine, Inc. Via GlobeNewswire Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session April 29, 2024 Via Benzinga Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday April 29, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday April 29, 2024 Pre-market stock movers are a great way to start the week as we check out all of the biggest news moving shares on Monday! Via InvestorPlace Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD) April 29, 2024 From Prime Medicine, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's After-Market Session April 26, 2024 Via Benzinga Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings April 23, 2024 From Prime Medicine, Inc. Via GlobeNewswire 2 Magnificent Growth Stocks With Room to Run March 27, 2024 These deeply undervalued growth stocks could be big winners for patient shareholders. Via The Motley Fool Short-Squeeze Roulette: 3 Stocks That Could Leave Bears Begging March 14, 2024 Explore short-squeeze stocks for potential surges, spotlighting investor strategies and trends that could benefit your portfolio. Via InvestorPlace Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too? March 01, 2024 On the leading edge of rare disease treatment and therapy is where you will find these Cathie Wood biotech stocks. Via InvestorPlace Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates March 01, 2024 From Prime Medicine, Inc. Via GlobeNewswire Prime Medicine to Participate in Upcoming Investor Conferences February 28, 2024 From Prime Medicine, Inc. Via GlobeNewswire Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares February 20, 2024 From Prime Medicine, Inc. Via GlobeNewswire Prime Medicine Announces Pricing of Upsized Public Offering February 14, 2024 From Prime Medicine, Inc. Via GlobeNewswire Prime Medicine Announces Proposed Public Offering of Common Stock February 14, 2024 From Prime Medicine, Inc. Via GlobeNewswire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.